Daniel C. Ihde - Concepedia

Author

Daniel C. Ihde

Also Known As

D C Ihde, D. C. Ihde, D. Ihde, D.C. Ihde, DANIEL C. IHDE, DANIEL IHDE, DC Ihde, Daniel C Ihde, Daniel C. Ihde, Daniel Ihde

146

Publications

11.4K

Citations

H-Index

Concepts

All Affiliations

National Cancer Institute Center for Neuro-Oncology Naval Medical Research Command United States Department of Veterans Affairs National Institutes of Health

About

Daniel C. Ihde is an author at National Cancer Institute specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	41	76	6.1K
2	Health Sciences	23	28	2.5K
3	Cell Biology	9	9	829
4	Gastroenterology	3	3	226
5	Allergy	1	1	26

Daniel C. Ihde

Publications

8.4K

Citations

H-Index

Page 1

	Year	Citations
A Randomized Trial Comparing Combination Electron-Beam Radiation and Chemotherapy with Topical Therapy in the Initial Treatment of Mycosis Fungoides Frederic J. Kaye, Paul A. Bunn, Seth M. Steinberg, New England Journal of Medicine PathologyMetronomic ChemotherapyDermatologyImmunotherapyHematological Malignancy	1989	492
CNS metastases in small cell bronchogenic carcinoma.Increasing frequency and changing pattern with lengthening survival John L. Nugent, Paul A. Bunn, Mary J. Matthews, Cancer	1979	483
Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure. Dan L. Longo, P L Duffey, Robert C. Young, Journal of Clinical Oncology	1992	376
The treatment of indolent lymphomas: watchful waiting v aggressive combined modality treatment. Robert C. Young, Daniele Longo, Eli Glatstein, PubMed	1988	313
NCI-navy medical oncology branch cell line data base Ruby Phelps, Bruce E. Johnson, Daniel C. Ihde, Journal of Cellular Biochemistry	1996	304
Staging and prognostic factors in small cell lung cancer: a consensus report Rolf A. Stahel, Robert J. Ginsberg, K. Havemann, Lung Cancer Prognostic FactorsMedicineConsensus ReportPathologyBronchial Neoplasm	1989	267
Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer. Daniel C. Ihde, James L. Mulshine, B S Kramer, Journal of Clinical Oncology	1994	251
myc family oncogene amplification in tumor cell lines established from small cell lung cancer patients and its relationship to clinical status and course. Bruce E. Johnson, Daniel C. Ihde, Robert Makuch, Journal of Clinical Investigation C-myc Dna AmplificationPathologyCancer BiologyTumor BiologyOncology	1987	245
Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial. Daniele Longo, Vincent T. DeVita, P L Duffey, Journal of Clinical Oncology Hematological MalignancyLymphoid NeoplasiaSurgical OncologyStage IiComplete Response Rate	1991	219
A randomized trial of standard chemotherapy v a high-dose chemotherapy regimen in the treatment of poor prognosis nonseminomatous germ-cell tumors. Robert F. Ozols, Daniel C. Ihde, W. Marston Linehan, Journal of Clinical Oncology UrologyMedicineStandard ChemotherapyCancer ManagementPathology	1988	208

Page 1